Trial no.:
|
PACTR202311772437904 |
Date of Approval:
|
06/11/2023 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
A Comparison Between Ultrasound Guided Erector Spinae Block Using Bupivacaine versus Bupivacaine & Dexmedetomidine for Postoperative Analgesia in Patients Undergoing Percutaneous Nephrolithotomy: A Randomized Controlled Double-Blinded Study
|
Official scientific title |
A Comparison Between Ultrasound Guided Erector Spinae Block Using Bupivacaine versus Bupivacaine & Dexmedetomidine for Postoperative Analgesia in Patients Undergoing Percutaneous Nephrolithotomy: A Randomized Controlled Double-Blinded Study
|
Brief summary describing the background
and objectives of the trial
|
Percutaneous nephrolithotomy (PCNL) is a popular and effective treatment for large kidney stones. The Erector Spinae block (ESB) is a regional anesthetic technique that can provide pain relief for patients undergoing PCNL. Adding the drug dexmedetomidine to the local anesthetic used in ESB can extend the duration of sensory and motor block and reduce postoperative pain.
This study aimed to assess the safety and efficacy of adding dexmedetomidine as an adjuvant to the local anesthetic used in ESB in patients scheduled for PCNL.
Fifty patients were randomly divided into two groups (25 each). Group A received the local anesthetic bupivacaine alone, while Group B received bupivacaine plus dexmedetomidine. The researchers recorded the postoperative 24-hour morphine consumption, intraoperative fentanyl consumption, intraoperative hemodynamics, and side effects as nausea, vomiting, bleeding, or organ injury. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
01/01/2021 |
Actual trial start date |
01/01/2021 |
Anticipated date of last follow up |
30/06/2021 |
Actual Last follow-up date |
30/06/2021 |
Anticipated target sample size (number of participants) |
50 |
Actual target sample size (number of participants) |
|
Recruitment status |
Completed |
Publication URL |
|
|